Author Information
Raymond Gilles Schlienger is a prominent researcher in the field of epidemiology, currently affiliated with Quantitative Safety and Epidemiology at Novartis Pharma AG, located in Basel, Switzerland. His work primarily focuses on the epidemiology of heart failure, with specific interest in pharmacological treatments and their impacts on patient outcomes.Research Contributions
Raymond Gilles Schlienger has made significant contributions to the understanding of heart failure management through his extensive research. His studies have explored various aspects of heart failure, including hospitalization rates, physician adjudication of angioedema, and the use of sodium-glucose cotransporter-2 inhibitors and sacubitril/valsartan. His research extends beyond heart failure to include studies on community health education programs in Kenya and rehabilitation tools for Parkinson's disease gait impairment. Schlienger's work utilizes large datasets from electronic health records, enabling comprehensive analyses of patient and treatment characteristics.Aliases
Throughout his career, Raymond Gilles Schlienger has published under various aliases, including R Schlienger, Raymond Schlienger, R.g. Schlienger, Raymond G. Schlienger, Raymondg. Schlienger, Raymond G Schlienger, R. G. Schlienger, Raymond Gilles Schlienger, and R G Schlienger. These variations reflect the diverse ways his name may appear across different publications and databases.Publication and Citation Metrics
| Metric |
Value |
| Total Citation Count |
5629 |
| H-index |
39 |
| Total Paper Count |
119 |
